Her2 Positive Breast Cancer What Can You Expect Mayo Clinic Press

HER2-positive Breast Cancer: What Can You Expect? - Mayo Clinic Press

HER2-positive Breast Cancer: What Can You Expect? - Mayo Clinic Press Her2 positive breast cancer is a breast cancer that tests positive for a protein called human epidermal growth factor receptor 2 (her2). this protein promotes the growth of cancer cells. El cáncer de mama her2 positivo es un tipo de cáncer que da un resultado positivo para una proteína llamada receptor 2 del factor de crecimiento epidérmico humano (her2). esta proteína fomenta el crecimiento de las células cancerosas. en aproximadamente 1 de cada 5 cánceres de mama, las.

HER2-positive Breast Cancer: What Can You Expect? - Mayo Clinic Press

HER2-positive Breast Cancer: What Can You Expect? - Mayo Clinic Press Breast cancer types include ductal carcinoma and lobular carcinoma. learn about these and other types of breast cancer. مرض سرطان الثدي الإيجابي her2 يميل إلى أن يكون أكثر شدة بكثير من أنواع أخرى من سرطان الثدي. العلاجات التي تستهدف هرمون her2 تكون فعالة للغاية. Her2 阳性乳腺癌是一种被称为人表皮生长因子受体 2（her2）的蛋白质检测呈阳性的乳腺癌。 这种蛋白质对癌细胞的生长有促进作用。. Invasive lobular carcinomas are less likely to make extra her2, so they're less likely to respond to this treatment. your treatment plan will depend on many factors. your healthcare team considers the stage of the cancer and how quickly it's growing. your care team also considers your overall health and what you prefer. breast cancer surgery.

HER2-positive Breast Cancer: What Can You Expect? - Mayo Clinic Press

HER2-positive Breast Cancer: What Can You Expect? - Mayo Clinic Press Her2 阳性乳腺癌是一种被称为人表皮生长因子受体 2（her2）的蛋白质检测呈阳性的乳腺癌。 这种蛋白质对癌细胞的生长有促进作用。. Invasive lobular carcinomas are less likely to make extra her2, so they're less likely to respond to this treatment. your treatment plan will depend on many factors. your healthcare team considers the stage of the cancer and how quickly it's growing. your care team also considers your overall health and what you prefer. breast cancer surgery. 乳腺癌细胞产生大量过多的 her2 蛋白，称为 her2 阳性。 使用会损伤产生过多 her2 的细胞的药物进行靶向治疗可能有助于控制这种乳腺癌。. Trastuzumab injection is used to treat her2 overexpressing new or metastatic (cancer that has spread) breast cancer. it can be used alone or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel). Her2 positive breast cancer triple negative breast cancer high grade breast cancers cancers that have spread to the lymph nodes larger breast cancers chemotherapy as the primary treatment for advanced breast cancer if breast cancer has spread to other parts of your body and surgery isn't an option, chemotherapy can be used as the primary treatment. Targeted therapy. if your cancer makes extra her2 protein, drugs that target that protein can help decrease the chance of the cancer recurring. bone building drugs. taking bone building drugs reduces the risk of cancer recurring in the bones (bone metastasis) in people with an increased risk for breast cancer recurrence. maintaining a healthy.

HER2-positive Breast Cancer: What Can You Expect? - Mayo Clinic Press

HER2-positive Breast Cancer: What Can You Expect? - Mayo Clinic Press 乳腺癌细胞产生大量过多的 her2 蛋白，称为 her2 阳性。 使用会损伤产生过多 her2 的细胞的药物进行靶向治疗可能有助于控制这种乳腺癌。. Trastuzumab injection is used to treat her2 overexpressing new or metastatic (cancer that has spread) breast cancer. it can be used alone or with other cancer medicines (eg, carboplatin, cyclophosphamide, docetaxel, doxorubicin, paclitaxel). Her2 positive breast cancer triple negative breast cancer high grade breast cancers cancers that have spread to the lymph nodes larger breast cancers chemotherapy as the primary treatment for advanced breast cancer if breast cancer has spread to other parts of your body and surgery isn't an option, chemotherapy can be used as the primary treatment. Targeted therapy. if your cancer makes extra her2 protein, drugs that target that protein can help decrease the chance of the cancer recurring. bone building drugs. taking bone building drugs reduces the risk of cancer recurring in the bones (bone metastasis) in people with an increased risk for breast cancer recurrence. maintaining a healthy.

ALTTO Trials Findings For Treating HER2+ Breast Cancer - Mayo Clinic